| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Battery Ventures XIV, L.P. | 22% | $6,019,428 | 11,575,824 | Battery Ventures XIV, L.P. | 23 Jun 2025 | |||
| Harbert Discovery Fund, LP | 9.9% | $2,691,475 | 5,175,913 | Harbert Fund Advisors, Inc. | 23 Jun 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of ENZO BIOCHEM INC - Common Stock (ENZB). This represents 0% of the company’s total 52,265,866 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$253,810 | $0.70 | 0 |
| 2025 Q2 | 374,753 | $253,811 | -$4,837,141 | $0.68 | 5 |
| 2025 Q1 | 13,413,698 | $4,960,065 | -$113,496 | $0.37 | 38 |
| 2024 Q4 | 13,597,198 | $9,711,626 | -$7,197 | $0.71 | 41 |
| 2024 Q3 | 12,649,378 | $14,167,341 | +$297,645 | $1.12 | 43 |
| 2024 Q2 | 12,379,977 | $13,491,693 | -$1,815,129 | $1.09 | 39 |
| 2024 Q1 | 13,822,512 | $17,554,428 | -$1,343,327 | $1.27 | 40 |
| 2023 Q4 | 16,327,612 | $22,693,718 | -$253,300 | $1.39 | 42 |
| 2023 Q3 | 16,509,108 | $23,111,255 | -$4,047,064 | $1.40 | 37 |
| 2023 Q2 | 18,837,559 | $34,660,589 | -$1,844,761 | $1.84 | 47 |
| 2023 Q1 | 19,784,854 | $48,075,146 | +$2,515,079 | $2.43 | 52 |
| 2022 Q4 | 18,742,600 | $26,800,042 | -$532,717 | $1.43 | 47 |
| 2022 Q3 | 20,460,994 | $45,627,000 | -$1,361,308 | $2.23 | 41 |
| 2022 Q2 | 20,838,167 | $43,133,000 | -$1,091,419 | $2.07 | 44 |
| 2022 Q1 | 21,380,401 | $62,010,000 | -$400,278 | $2.90 | 42 |
| 2021 Q4 | 21,469,984 | $68,922,860 | -$9,555,828 | $3.21 | 48 |
| 2021 Q3 | 23,430,169 | $82,922,591 | -$2,413,074 | $3.54 | 57 |
| 2021 Q2 | 24,166,464 | $76,606,267 | -$9,638,535 | $3.17 | 65 |
| 2021 Q1 | 25,079,498 | $86,260,268 | -$5,566,452 | $3.44 | 75 |
| 2020 Q4 | 29,192,805 | $73,573,557 | +$1,176,280 | $2.52 | 74 |
| 2020 Q3 | 25,336,346 | $53,452,881 | +$432,028 | $2.11 | 75 |
| 2020 Q2 | 28,360,629 | $63,528,502 | -$454,825 | $2.24 | 72 |
| 2020 Q1 | 28,570,211 | $72,280,987 | -$8,628,926 | $2.53 | 64 |
| 2019 Q4 | 31,923,615 | $83,959,164 | -$1,543,118 | $2.63 | 70 |
| 2019 Q3 | 32,624,584 | $117,446,930 | +$1,018,946 | $3.60 | 80 |
| 2019 Q2 | 32,451,127 | $109,360,796 | +$3,004,872 | $3.37 | 89 |
| 2019 Q1 | 32,152,748 | $87,769,028 | +$895,998 | $2.73 | 74 |
| 2018 Q4 | 31,775,434 | $88,334,227 | -$4,737,291 | $2.78 | 80 |
| 2018 Q3 | 31,314,610 | $129,005,010 | -$2,246,412 | $4.12 | 91 |
| 2018 Q2 | 31,922,535 | $165,661,708 | +$2,319,069 | $5.19 | 88 |
| 2018 Q1 | 30,566,801 | $167,499,130 | -$2,631,010 | $5.48 | 98 |
| 2017 Q4 | 30,733,425 | $250,516,184 | +$6,173,604 | $8.15 | 112 |
| 2017 Q3 | 29,804,124 | $312,062,304 | +$7,635,412 | $10.47 | 111 |
| 2017 Q2 | 29,100,857 | $321,277,301 | +$11,528,196 | $11.04 | 114 |
| 2017 Q1 | 28,290,490 | $236,774,952 | +$32,099,981 | $8.37 | 108 |
| 2016 Q4 | 26,922,182 | $186,827,845 | +$1,907,355 | $6.94 | 104 |
| 2016 Q3 | 23,713,946 | $120,696,418 | -$2,786,819 | $5.09 | 108 |
| 2016 Q2 | 24,267,906 | $144,877,758 | +$14,267,174 | $5.97 | 100 |
| 2016 Q1 | 22,131,652 | $100,549,000 | +$845,360 | $4.55 | 91 |
| 2015 Q4 | 21,913,257 | $98,614,619 | +$6,345,705 | $4.50 | 81 |
| 2015 Q3 | 21,065,810 | $66,780,568 | +$1,153,834 | $3.17 | 76 |
| 2015 Q2 | 19,409,652 | $58,806,030 | -$3,866,988 | $3.03 | 80 |
| 2015 Q1 | 21,860,556 | $64,512,225 | +$809,561 | $2.95 | 80 |
| 2014 Q4 | 21,323,065 | $94,673,944 | +$5,863,336 | $4.44 | 83 |
| 2014 Q3 | 19,619,196 | $101,032,804 | +$12,786,304 | $5.15 | 90 |
| 2014 Q2 | 17,131,392 | $89,871,177 | +$21,163,827 | $5.25 | 82 |
| 2014 Q1 | 13,274,771 | $55,208,893 | +$8,808,246 | $4.16 | 59 |